Bicycle Therapeutics PLCNASDAQ:BCYC
- LAST PRICE20.0900
- TODAY'S CHANGE (%)-0.1400 (-0.6920%)
- Bid / Lots20.1000/ 1
- Ask / Lots21.8100/ 1
- Open / Previous Close20.3100 / 20.2300
- Day Range
- 52 Week Range
- Volume335,445
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BCYC |
|---|---|---|
| 09:32 ET | 355 | 20.31 |
| 09:39 ET | 1088 | 20.31 |
| 09:41 ET | 200 | 20.385 |
| 09:43 ET | 100 | 20.4 |
| 09:45 ET | 200 | 20.32 |
| 09:50 ET | 200 | 20.295 |
| 09:56 ET | 200 | 20.26 |
| 09:57 ET | 250 | 20.215 |
| 09:59 ET | 100 | 20.215 |
| 10:01 ET | 322 | 20.29 |
| 10:03 ET | 300 | 20.255 |
| 10:06 ET | 2150 | 20.185 |
| 10:08 ET | 100 | 20.26 |
| 10:14 ET | 100 | 20.29 |
| 10:19 ET | 100 | 20.225 |
| 10:21 ET | 525 | 20.0933 |
| 10:26 ET | 100 | 20.08 |
| 10:28 ET | 1102 | 19.88 |
| 10:30 ET | 1223 | 19.96 |
| 10:32 ET | 300 | 20.01 |
| 10:35 ET | 300 | 20 |
| 10:42 ET | 100 | 20.04 |
| 10:44 ET | 100 | 19.91 |
| 10:48 ET | 600 | 20.05 |
| 10:50 ET | 200 | 20.155 |
| 10:53 ET | 100 | 20.19 |
| 10:55 ET | 200 | 20.145 |
| 10:57 ET | 200 | 20.21 |
| 11:00 ET | 200 | 20.15 |
| 11:02 ET | 600 | 20.19 |
| 11:04 ET | 100 | 20.23 |
| 11:06 ET | 100 | 20.19 |
| 11:09 ET | 512 | 20.24 |
| 11:13 ET | 600 | 20.18 |
| 11:18 ET | 100 | 20.18 |
| 11:20 ET | 413 | 20.13 |
| 11:22 ET | 200 | 20.12 |
| 11:26 ET | 200 | 20.17 |
| 11:27 ET | 100 | 20.05 |
| 11:38 ET | 100 | 19.87 |
| 11:40 ET | 400 | 19.87 |
| 11:42 ET | 100 | 19.85 |
| 11:47 ET | 400 | 19.8905 |
| 11:49 ET | 2315 | 19.98 |
| 11:54 ET | 100 | 20.03 |
| 11:58 ET | 100 | 19.92 |
| 12:00 ET | 100 | 19.99 |
| 12:02 ET | 100 | 19.92 |
| 12:05 ET | 450 | 19.9621 |
| 12:09 ET | 1600 | 19.97 |
| 12:16 ET | 100 | 20 |
| 12:21 ET | 1329 | 19.99 |
| 12:27 ET | 100 | 20.09 |
| 12:32 ET | 200 | 20.04 |
| 12:34 ET | 100 | 20.09 |
| 12:38 ET | 100 | 20.07 |
| 12:39 ET | 300 | 20.06 |
| 12:48 ET | 100 | 20.03 |
| 12:52 ET | 400 | 19.94 |
| 12:54 ET | 200 | 20 |
| 12:56 ET | 400 | 20 |
| 12:57 ET | 208 | 20.03 |
| 12:59 ET | 300 | 20.055 |
| 01:01 ET | 100 | 20.09 |
| 01:08 ET | 100 | 20.1 |
| 01:19 ET | 300 | 20.11 |
| 01:24 ET | 800 | 20.06 |
| 01:30 ET | 100 | 20.12 |
| 01:32 ET | 100 | 20.116 |
| 01:35 ET | 200 | 20.11 |
| 01:42 ET | 100 | 20.12 |
| 01:46 ET | 500 | 20.06 |
| 01:48 ET | 200 | 20.06 |
| 01:50 ET | 205 | 20.06 |
| 01:51 ET | 300 | 20.055 |
| 01:53 ET | 500 | 20.07 |
| 01:57 ET | 200 | 20.07 |
| 02:00 ET | 100 | 20.07 |
| 02:04 ET | 100 | 20.09 |
| 02:08 ET | 550 | 20.06 |
| 02:09 ET | 700 | 20.05 |
| 02:11 ET | 100 | 20.06 |
| 02:13 ET | 500 | 20.1 |
| 02:15 ET | 100 | 20.14 |
| 02:22 ET | 200 | 20.03 |
| 02:27 ET | 100 | 20.12 |
| 02:29 ET | 100 | 20.085 |
| 02:40 ET | 100 | 20.11 |
| 02:42 ET | 1025 | 20.06 |
| 02:45 ET | 606 | 20.15 |
| 02:51 ET | 500 | 20.17 |
| 02:56 ET | 100 | 20.18 |
| 02:58 ET | 219 | 20.12 |
| 03:00 ET | 798 | 20.18 |
| 03:02 ET | 101 | 20.21 |
| 03:03 ET | 100 | 20.26 |
| 03:07 ET | 200 | 20.19 |
| 03:09 ET | 200 | 20.16 |
| 03:12 ET | 700 | 20.12 |
| 03:14 ET | 200 | 20.1 |
| 03:16 ET | 293 | 20.165 |
| 03:18 ET | 200 | 20.12 |
| 03:20 ET | 500 | 20.12 |
| 03:21 ET | 1090 | 20.09 |
| 03:23 ET | 400 | 20.1 |
| 03:25 ET | 300 | 20.12 |
| 03:27 ET | 200 | 20.07 |
| 03:30 ET | 249 | 20.06 |
| 03:32 ET | 500 | 20 |
| 03:34 ET | 500 | 19.95 |
| 03:36 ET | 200 | 19.98 |
| 03:38 ET | 1117 | 20.01 |
| 03:39 ET | 1361 | 20.06 |
| 03:41 ET | 259 | 20.03 |
| 03:43 ET | 278 | 20.03 |
| 03:45 ET | 1438 | 20.04 |
| 03:48 ET | 200 | 20.055 |
| 03:50 ET | 343 | 20.03 |
| 03:52 ET | 700 | 20.11 |
| 03:54 ET | 1000 | 20.1 |
| 03:56 ET | 11677 | 20.1 |
| 03:57 ET | 5039 | 20.135 |
| 03:59 ET | 51752 | 20.09 |
Sep 12, 2023
DJ Bicycle Therapeutics Raised to Buy From Neutral by B. Riley Securities, from 10:04AM ET on Tuesday Sep 12, 2023 by Dow Jones
10:04AM ET on Tuesday Sep 12, 2023 by Dow JonesDJ Bicycle Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:15AM ET on Tuesday Sep 12, 2023 by Dow Jones
9:15AM ET on Tuesday Sep 12, 2023 by Dow JonesDJ Bicycle Therapeutics Price Target Maintained With a $44.00/Share by JMP Securities, from 8:14AM ET on Tuesday Sep 12, 2023 by Dow Jones
8:14AM ET on Tuesday Sep 12, 2023 by Dow JonesDJ Bicycle Therapeutics Price Target Maintained With a $46.00/Share by Needham, from 5:36AM ET on Tuesday Sep 12, 2023 by Dow Jones
5:36AM ET on Tuesday Sep 12, 2023 by Dow Jones
Sep 11, 2023
DJ Bicycle Therapeutics Raised to Buy From Neutral by B. Riley Securities, from 2:08PM ET on Monday Sep 11, 2023 by Dow Jones
2:08PM ET on Monday Sep 11, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bicycle Therapeutics PLC | 837.9M | -4.3x | --- |
Cogent Biosciences Inc | 837.6M | -4.4x | --- |
Verve Therapeutics Inc | 825.8M | -4.2x | --- |
Belite Bio Inc | 867.3M | -29.3x | --- |
Inhibrx Inc | 795.2M | -4.5x | --- |
Pharvaris NV | 828.2M | -7.6x | --- |
Company Information
Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a class of medicines, which it refers to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are therapeutic modality combining the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Its product candidates BT5528, BT8009 and BT1718, are each a Bicycle Toxin Conjugate (BTC). BT5528 is a second-generation BTC designed to target Ephrin type A receptor 2 (EphA2). BT8009 is a second-generation BTC designed to target Nectin-4, a validated tumor antigen. BT1718 is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase (MT1 MMP). Its product candidates BT7480 and BT7455, are each a Bicycle tumor-targeted immune cell agonist (TICA). The Company is also focused on additional therapeutic areas other than its wholly owned oncology portfolio.
Contact Information
- Headquarters
- Babraham HallCAMBRIDGE, United Kingdom CB21 6GS
- Phone
- 122-326-1503
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Pierre Legault
- Chief Executive Officer, Executive Director
- Kevin Lee
- Chief Financial Officer, Principal Financial Officer
- Alethia Young
- Chief Operating Officer
- Alistair Milnes
- Chief Technology Officer
- Michael Skynner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $837.9M |
|---|---|
Revenue (TTM) | $22.5M |
Shares Outstanding | 41.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-4.68 |
Book Value | $9.06 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 37.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -652.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
